Biotredin sublingv tab. 105mg 30 pieces

Description

Composition
Active substance:
Threonine – 100 mg, pyridoxine hydrochloride – 5 mg ;.
Excipients:
Povidone (K17) – 3.51 mg citric acid monohydrate – 0.59 mg lactose monohydrate – 6.73 mg magnesium stearate – 1.17 mg.
Description:
Round Valium tablets of white or cream-colored with a chamfer.
Product form:
Sublingual tablets, 5 mg + 100 mg. 30 tablets in blisters of PVC film and aluminum foil. 1 contour cellular packaging together with instructions for use in a pile of cardboard.
Contraindications
Alcoholic intoxication, simultaneous drugs which depress the central nervous system (anxiolytics, antipsychotics (neuroleptics), antidepressants, etc.), Increased sensitivity to vitamin B6.
Not recommended for use in congenital galactosemia, glucose malabsorption syndrome and congenital lactase deficiency, because of the drug includes lactose.
Dosage
5 mg + 100 mg
Indications
Administered to children, adolescents and adults with a decrease in mental performance and concentration.
The drug is prescribed for persons who abuse alcohol, patients with chronic alcoholism when updating the craving for alcohol, coupled with mood (irritability, depressed mood, internal discomfort), sensory (hunger) and ideational (thoughts about alcohol) disorders, with alcohol withdrawal syndrome, and and to maintain remission.
Interaction with other drugs
Incompatible with antipsychotic drugs, antidepressants, anxiolytics, barbiturates. Reduces the effect of antipsychotics (neuroleptics), antidepressants, barbiturates and other drugs which depress the central nervous system.
Overdose
Cases of overdose have been identified.
pharmachologic effect
Pharmacological group:
B vitamins + other drugs.
Pharmacodynamics:
Biotredin® is a regulator of tissue metabolism, improves mental performance, has a therapeutic effect in the alcohol withdrawal condition, reduces the craving for alcohol.
Threonine in the presence of pyridoxine (vitamin B6) decomposes into amino acid glycine and acetaldehyde, which stimulate the braking process and simultaneously the oxidation-reduction reactions, the processes of respiration and the synthesis of adenosine triphosphate (ATP) in the cells, whereby the drug is able to: improve short and long term memory; improve mental performance; reduce emotional stress; improve and normalize the levels of endogenous acetaldehyde and thereby reduce the effect of alcohol withdrawal symptoms and craving for alcohol.
Action Biotredina® manifested in 10-20 minutes after administration under the tongue.
Pharmacokinetics:
Threonine and pyridoxine completely metabolized to the final products. Their accumulation does not occur in the body.
Pregnancy and breast-feeding
Individual studies have been conducted. Not recommended for use during pregnancy and lactation.
When alcohol abuse and alcoholism, the drug can be used during pregnancy and while breast-feeding, if the expected therapeutic effect is greater than the risk of possible side effects.
Conditions of supply of pharmacies
Available without prescription.
side effects
Dizziness, increased sweating, allergic reactions, intolerance to vitamin B6.
special instructions
Not recommended for use in a drunken period since decreases therapeutic effect of the drug. The preparation includes lactose, in connection with which it is not recommended for patients with congenital galactosemia, malabsorption syndrome or glucose in congenital lactase deficiency.
The possibility of influence of the drug on the ability to drive vehicles and other potentially dangerous machines: No effect.
Storage conditions
In the dark place at a temperature not higher than 25 ° C. Keep out of the reach of children.
Dosing and Administration
The drug is prescribed in tablets under the tongue or in powder form after grinding pills. Biotredina® greatest effect is achieved when it is combined with the drug Glycine. 1 tablet (100 mg) Glycine taken sublingually for 10-15 minutes prior to receiving Biotredina®.
As a means of enhancing attention, mental performance: children, adolescents and adults: 1 tablet 2-3 times a day for 3-10 days. If necessary, repeat 3-4 times or more per year.
Treatment of alcohol withdrawal syndrome: the first day 1-4 tablets 3-4 times a day (daily dose of 3-16 tablets), on the second day and then 1-2 tablets to receive 2-3 times a day (daily dose 3- 6 tablets) for 21-28 days. The course can be reduced to 10-14 days.
Patients with chronic alcoholism and abusing alcohol: 1-3 tablets to receive 2-3 times a day for 4-5 days. If necessary, repeat 5-10 times a year.
In remission for detecting latent craving for alcohol: 2-3 tablets Biotredina® take on an empty stomach. The emergence within 10-20 minutes of light dizziness, sedative effect, facial flushing, sweating indicates the presence of “hidden traction.” In these cases it is recommended 5-10 day course Biotredina® with Glycine: 1-2 tablets 2-3 times a day. Glycine received 1 tablet (100 mg) under the tongue for 10-15 minutes prior to receiving Biotredina®.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist